HMGA2 and breast adenocarcinoma: Breast adenocarcinoma cells overexpressing HMGA2 exhibit fewer apoptotic events compared to cells with low HMGA2 expression by a mechanism involving HMGA2-mediated inhibition of miR-34a and subsequent de-repression of Bcl-2 [25].